Literature DB >> 6626279

The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee.

C A Smith, W J Fidler, R S Pinals.   

Abstract

We have studied the epidemiology of giant cell arteritis (GCA) in an urban population in south central United States. The incidence of GCA in Shelby County, Tennessee for the years 1971 through 1980 was determined for the total population and for age-, sex-, and race-specific groups. Over this period 26 cases were identified. The average annual incidence was 0.35/100,000. This was increased to 1.58/100,000 for those over the age of 50. The incidence was 7 times greater in whites than in blacks and 7 times greater in females than in males. Clinical and laboratory features of the patients were reviewed and found to be similar to those in other populations. GCA is considerably less frequent in Shelby County, Tennessee than in other areas where similar epidemiologic studies have been performed. This difference can be accounted for only in part by racial distributions. Similar studies in southern geographic areas are needed to place our findings in perspective and point to specific factors which may have etiologic significance in GCA.

Entities:  

Mesh:

Year:  1983        PMID: 6626279     DOI: 10.1002/art.1780261007

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

1.  Giant cell arteritis among Hispanic Americans.

Authors:  Byron L Lam; Robert S Wirthlin; Ariadna Gonzalez; Sander R Dubovy; William J Feuer
Journal:  Am J Ophthalmol       Date:  2006-08-28       Impact factor: 5.258

Review 2.  The geo-epidemiology of temporal (giant cell) arteritis.

Authors:  Jennifer L Lee; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 3.  Giant cell arteritis.

Authors:  Xiang Wang; Zhi Ping Hu; Wei Lu; Xiang Q Tang; He P Yang; Liu W Zeng; Jie Zhang; Ting Li
Journal:  Rheumatol Int       Date:  2008-08-21       Impact factor: 2.631

4.  Ophthalmic presentation of giant cell arteritis in African-Americans.

Authors:  S T Garrity; M Pistilli; M S Vaphiades; N Q Richards; P S Subramanian; P R Rosa; B L Lam; B J Osborne; G T Liu; K E Duncan; R K Shin; N J Volpe; K S Shindler; M S Lee; M L Moster; E H Tracey; S E Cuprill-Nilson; M A Tamhankar
Journal:  Eye (Lond)       Date:  2016-09-16       Impact factor: 3.775

Review 5.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

Review 6.  Giant cell arteritis with ocular complications discovered simultaneously in two sisters.

Authors:  F Gros; J F Maillefert; A Behin; F Guignier; C Piroth; C Creuzot-Garcher; C Tavernier
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

7.  New advances in bone research.

Authors:  H C Amstutz; E E Johnson; G A Finerman; R A Meals; J R Moreland; W C Kim; M R Urist
Journal:  West J Med       Date:  1984-07

Review 8.  Clinical features of polymyalgia rheumatica and giant cell arteritis.

Authors:  Carlo Salvarani; Nicolò Pipitone; Annibale Versari; Gene G Hunder
Journal:  Nat Rev Rheumatol       Date:  2012-07-24       Impact factor: 20.543

Review 9.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

10.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.